All News

Actively Recruiting Trials for Lung, Biliary, AML and Small Cell Cancer

September 15th 2025, 7:00pm

Article

Early trial results report progression-free survival and response rates for ateganosine, spevatamig, Annamycin and pumitamig; studies are currently enrolling.

The Lessons of the Woods

September 15th 2025, 5:00pm

Article

Walking the woods shows me how to release fear, grief, and expectations, trusting that letting go nourishes growth, resilience and life’s next season.

Prostatectomy Not Guaranteed to be Curative in Prostate Cancer

September 15th 2025, 4:00pm

Article

For men with prostate cancer, radical prostatectomy, or surgical removal of the prostate, isn’t guaranteed to be curative, as one expert explained.

FDA Grants Breakthrough Status to Raludotatug Deruxtecan in Ovarian Cancer

September 15th 2025, 3:00pm

Article

The FDA granted breakthrough therapy designation to R-DXd for adults with CDH6-expressing platinum-resistant ovarian, peritoneal or fallopian tube cancers.

Patient Advocate and Caregiver Shares Advocacy Journey in KRAS Cancers

September 15th 2025, 1:00pm

Video

Dr. Joshua Sabari spoke with advocate Chris Conneran on his journey from caregiver to champion for KRAS-mutant cancer patients and families.

The Seasons of Life: A Metaphor for Identity and Legacy

September 14th 2025, 6:00pm

Article

The changing seasons offer a profound metaphor for the circle of life, an idea that resonates deeply with me.

Real-World Study Finds Benefit of Lutathera in Patients With Lung NETs

September 14th 2025, 2:00pm

Article

Lutathera demonstrated antitumor activity in patients with metastatic bronchopulmonary neuroendocrine tumors.

Tepmetko Associated With Frequent Side Effects for Some With NSCLC

September 13th 2025, 6:00pm

Article

For patients with MET exon 14-altered NSCLC, Tepmetko was associated with frequent side effects, although the safety profile is considered manageable.

Understanding Prostate Cancer Surgery and Highlighting Patient Advocacy

September 13th 2025, 2:00pm

Video

As the prostate cancer treatment landscape continues to evolve, understanding the risks and benefits of each approach is critical for patients.

Standing Up to a Friend’s Cancer Is as Hard as Facing My Own

September 12th 2025, 9:00pm

Article

Receiving a “Stand Up to Cancer Day” email gave me the strength to support a friend through her darkest cancer days.